POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer

Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...

Read

PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer

The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...

Read

Moving Together for Change: The Journey to Fun Run Munich

The road to Fun Run Munich 2026 is well underway. Through training, community, and shared purpose, participants across Europe are preparing to walk...

Read

Munich Awaits: The DiCE Community Gears Up for the 11th Annual Masterclass

Excitement is building as the DiCE community prepares to gather in Munich for the 11th Annual Masterclass. From scientific discussions and advocacy...

Read

Europe’s Beating Cancer Plan: The Real Failure Is Implementation

On 14 April 2026, MEP Vlad Voiculescu (Renew, Romania) presented his report on the implementation of Europe’s Beating Cancer Plan in the European...

Read

Start Moving, Stay Moving: Your Path to the Fun Run 2026

Two practical webinars from DiCE and OAC break down the barriers to movement, showing how to start, stay motivated, and build sustainable habits. W...

Read

Rising Early-Onset Cancer: Rethinking Care for Younger Adults

Experts at TSJCI highlighted the growing burden of early-onset cancers, calling for tailored screening, multidisciplinary research, and age-appropr...

Read

IMPACT-CRC: Cracking the Code of Personalised Colorectal Cancer Treatment

IMPACT-CRC brings together partners to understand why colorectal cancer patients respond differently to treatment. Using AI and biomarker research,...

Read

Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment

Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...

Read

Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention

A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.